CF Pharmtech, Inc. recently successfully completed series E round financing of RMB630 million (US$90 million). This round of financing is led by the United new capital investment, CR-CP Life, Junxin capital, Source Venture Capital, Cornerstone Capital, Xiangcheng District financial control, Langma Feng Investment and other well-known institutions also invested.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!